Provided by Tiger Fintech (Singapore) Pte. Ltd.

Arcturus Therapeutics Ltd.

14.95
-0.5000-3.24%
Post-market: 14.90-0.0500-0.33%19:49 EDT
Volume:252.36K
Turnover:3.79M
Market Cap:405.45M
PE:-5.93
High:15.50
Open:15.37
Low:14.78
Close:15.45
Loading ...

Arcturus Therapeutics to Report Second Quarter Financial Results and Provide Corporate Update on August 11, 2025

THOMSON REUTERS
·
7 hours ago

Arcturus Therapeutics Holdings Inc. to Participate in BTIG Virtual Biotechnology Conference 2025

Reuters
·
Yesterday

Analysts Offer Insights on Healthcare Companies: Arcturus Therapeutics (ARCT) and Pharvaris (PHVS)

TIPRANKS
·
15 Jul

William Blair Reaffirms Their Buy Rating on Arcturus Therapeutics (ARCT)

TIPRANKS
·
06 Jul

Arcturus Therapeutics Is Maintained at Sector Outperform by Scotiabank

Dow Jones
·
02 Jul

Scotiabank Sticks to Its Buy Rating for Arcturus Therapeutics (ARCT)

TIPRANKS
·
02 Jul

Cantor Fitzgerald Keeps Their Buy Rating on Arcturus Therapeutics (ARCT)

TIPRANKS
·
01 Jul

Citi adds ‘upside 90-day catalyst watch’ on Arcturus Therapeutics

TIPRANKS
·
01 Jul

Arcturus Therapeutics Says Phase 2 Interim Results of ARCT-810 Showed Reduced Glutamine Levels in OTC Deficiency

MT Newswires Live
·
30 Jun

BRIEF-Arcturus Therapeutics Announces Positive Interim Phase 2 Multiple Dose Data For OTC Deficiency Program

Reuters
·
30 Jun

Analysts Are Bullish on These Healthcare Stocks: Arcturus Therapeutics (ARCT), Gilead Sciences (GILD)

TIPRANKS
·
29 Jun

Arcturus Therapeutics Holdings Inc. to Announce Fourth Quarter 2025 Financial Results

Reuters
·
23 Jun

Citi Keeps Their Buy Rating on Arcturus Therapeutics (ARCT)

TIPRANKS
·
10 Jun

Arcturus Therapeutics Held Annual Stockholders Meeting

Reuters
·
07 Jun

Arcturus Therapeutics to Attend Upcoming Investor Conferences

Business Wire
·
30 May

Scotiabank Initiates Arcturus Therapeutics at Outperform

MT Newswires Live
·
28 May

William Blair Remains a Buy on Arcturus Therapeutics (ARCT)

TIPRANKS
·
21 May

Arcturus Therapeutics Is Maintained at Overweight by Wells Fargo

Dow Jones
·
14 May

Arcturus Therapeutics Is Maintained at Buy by Canaccord Genuity

Dow Jones
·
13 May

Arcturus Therapeutics Holdings Inc reports results for the quarter ended March 31 - Earnings Summary

Reuters
·
13 May